A gene delivery/recall system for neurons which utilizes ribonucleotide reductase-negative herpes simplex viruses
- PMID: 1656596
- DOI: 10.1016/0042-6822(91)90794-c
A gene delivery/recall system for neurons which utilizes ribonucleotide reductase-negative herpes simplex viruses
Abstract
We present data which show that ribonucleotide (RR)-negative herpes simplex virus type-1 (HSV-1) is a useful vector for gene delivery into neuronal cells. For these studies we used hrR3, a genetically engineered HSV-1 mutant which has an in-frame insertion of the bacterial lacZ gene into the HSV gene that encodes the large subunit (ICP6) of RR. After infection of rat primary sympathetic neuronal cultures with hrR3, the ICP6::lacZ chimeric gene was expressed, as shown by blue staining of the cells upon exposure to X-Gal, a chromogenic beta-galactosidase substrate. When the infection was performed in the presence of acyclovir, hrR3 appeared to become "latent"; neither infectious virus nor beta-galactosidase activity was detectable in these neuronal cultures at 3 weeks after the acyclovir was removed. However, beta-galactosidase activity was inducible in the "latent" cultures by superinfection with ICP6 delta (a RR-negative deletion mutant) without resulting in the "reactivation" of hrR3 and without apparent cytopathic effects. In contrast, superinfection with ICP6 delta + 3.1, a virus derived by marker rescue of ICP6 delta, resulted in the expression of lacZ, the release of hrR3 into the culture medium, and cytopathic effects. The introduction of a foreign gene into neuronal cells by a RR-negative herpes simplex virus, and the subsequent induction of gene expression by another noncomplementing virus, may constitute a prototype gene delivery/recall system for neurons.
Similar articles
-
Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant.Virology. 1988 Sep;166(1):41-51. doi: 10.1016/0042-6822(88)90144-4. Virology. 1988. PMID: 2842955
-
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant.Cancer Res. 1994 Aug 1;54(15):3963-6. Cancer Res. 1994. PMID: 8033122
-
Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.J Virol. 1988 Jan;62(1):196-205. doi: 10.1128/JVI.62.1.196-205.1988. J Virol. 1988. PMID: 2824847 Free PMC article.
-
The herpes simplex virus ribonucleotide reductase is required for ocular virulence.J Gen Virol. 1991 Sep;72 ( Pt 9):2043-9. doi: 10.1099/0022-1317-72-9-2043. J Gen Virol. 1991. PMID: 1654368
-
Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors.Trends Neurosci. 1991 Oct;14(10):428-32. doi: 10.1016/0166-2236(91)90040-2. Trends Neurosci. 1991. PMID: 1722360 Review.
Cited by
-
Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.J Virol. 2004 Jul;78(13):6836-45. doi: 10.1128/JVI.78.13.6836-6845.2004. J Virol. 2004. PMID: 15194759 Free PMC article.
-
Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system.J Virol. 2000 Dec;74(23):11254-61. doi: 10.1128/jvi.74.23.11254-11261.2000. J Virol. 2000. PMID: 11070024 Free PMC article.
-
Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors.Theor Biol Med Model. 2011 Jun 24;8:23. doi: 10.1186/1742-4682-8-23. Theor Biol Med Model. 2011. PMID: 21702927 Free PMC article.
-
Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways.J Virol. 1996 Aug;70(8):5476-86. doi: 10.1128/JVI.70.8.5476-5486.1996. J Virol. 1996. PMID: 8764059 Free PMC article.
-
Effective vaccination against long-term gammaherpesvirus latency.J Virol. 2003 Feb;77(4):2522-9. doi: 10.1128/jvi.77.4.2522-2529.2003. J Virol. 2003. PMID: 12551990 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources